HomeOTLC • OTCMKTS
add
Oncotelic Therapeutics Inc
Previous close
$0.056
Day range
$0.052 - $0.059
Year range
$0.017 - $0.070
Market cap
21.61M USD
Avg Volume
145.92K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 31.45K | -72.28% |
Net income | -600.93K | 18.35% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 86.13K | -49.46% |
Total assets | 26.68M | -11.12% |
Total liabilities | 19.20M | 4.33% |
Total equity | 7.48M | — |
Shares outstanding | 408.29M | — |
Price to book | 2.81 | — |
Return on assets | -0.29% | — |
Return on capital | -0.38% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -600.93K | 18.35% |
Cash from operations | -103.88K | 72.12% |
Cash from investing | — | — |
Cash from financing | 41.00K | -85.09% |
Net change in cash | -62.89K | 35.57% |
Free cash flow | 297.96K | -0.56% |
About
Founded
1988
Headquarters
Website
Employees
26
